Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures

Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures

Abstract We are now in an era of molecular medicine, where specific DNA alterations can be used to identify patients who will respond to specific drugs. However, there are only a handful of clinically used predictive biomarkers in oncology. Herein, we describe an approach utilizing in vitro DNA and...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas R. Rydzewski, Erik Peterson, Joshua M. Lang, Menggang Yu, S. Laura Chang, Martin Sjöström, Hamza Bakhtiar, Gefei Song, Kyle T. Helzer, Matthew L. Bootsma, William S. Chen, Raunak M. Shrestha, Meng Zhang, David A. Quigley, Rahul Aggarwal, Eric J. Small, Daniel R. Wahl, Felix Y. Feng, Shuang G. Zhao
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Genetics
QH426-470
Online Access:https://doaj.org/article/683460200e2546bd8518fb156fad7efa
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/683460200e2546bd8518fb156fad7efa

Similar Items